dr holst glp-1 Tech Talk - The Discovery of Hormone Researcher receives prize for huge

Foundayo (Orforglipron): The New Oral Option Orforglipron's April 2026 approval is notable for several reasons

Our brain sets an ideal weight for our body (influenced by many different factors) in the same way it sets our body temperature or breathing rate

As of January 2025, Ozempic is now approved for use in patients with type 2 diabetes who also have chronic kidney disease

32(2): e131

Myers' Cocktail, NAD+, glutathione, and custom formulations delivered intravenously to support efficient absorption and fast, targeted replenishment

Similarly, oral vitamin B12 absorption can be as low as 1-2% in individuals lacking intrinsic factor, a vital protein for its intestinal uptake